Ann Thorac Surg 2006;82:357-364
© 2006 The Society of Thoracic Surgeons
Review
Current Strategies in the Management of Atrial Fibrillation
Marjan Jahangiri, FRCS
a
,
*
,
Graeme Weir, MRCS
a
,
Kaushik Mandal, FRCS
a
,
Irina Savelieva, MD
b
,
John Camm, FRCP
b
a Department of Cardiac Surgery, St. George's Hospital Medical School, London, United Kingdom
b Department of Cardiac and Vascular Sciences, St. George's Hospital Medical School, London, United Kingdom
* Address correspondence to Dr Jahangiri, Department of Cardiac Surgery, St. George's Hospital, Blackshaw Road, London SW17 OQT, United Kingdom (Email: marjan.jahangiri{at}stgeorges.nhs.uk).
 |
Abstract
|
|---|
Treatment of atrial fibrillation (AF) has been undergoing significant changes recently. This is due partly to different mechanisms proposed for persistent and permanent AF and partly due to the introduction of energy-based techniques, providing less invasive procedures. This article aims to review the mechanisms of AF leading to the changes in clinical practice and to review the results of surgery, energy-based, and percutaneous techniques. It is difficult to compare and contrast the results of reported series in the literature due to different definitions of AF; freedom from and recurrence of it. Furthermore, in most series it is difficult to distinguish results of surgery for lone AF and AF associated with valvular heart disease and coronary artery disease.
 |
Material and Methods
|
|---|
An English literature search using the Pubmed-Medline database between 1960 and today was carried out. Key words used included fibrillation, atrial fibrillation (AF), cardiac surgery, surgery, ablation, and percutaneous ablation. A search on energy-based techniques using the key words radiofrequency, microwave, and cryothermy was also carried out.
 |
Definition of AF
|
|---|
The use of inconsistent terminology in different studies has made comparison and analysis of literature difficult. Some of the terms used include paroxysmal, persistent, permanent, intermittent, chronic, and continuous. The American College of Cardiology, American Heart Association, and European Society of Cardiology practice guidelines [1] recommend that when a patient has had two or more episodes, AF is considered recurrent. Once terminated, recurrent AF is designated paroxysmal and when sustained is designated persistent. Persistent AF does not terminate spontaneously and requires electrical and/or pharmacologic measures to restore sinus rhythm. However, permanent AF is not cardioverted by electrical and/or pharmacologic measures. We have previously classified AF into acute and chronic; acute having an onset within 24 to 48 hours with a high chance of cardioversion and chronic consisting of paroxysmal, persistent, and permanent [2, 3].
 |
Incidence of AF
|
|---|
The incidence of AF, the most common cardiac arrhythmia in the general population [4], is increasing as the population ages [5, 6]. The incidence of new-onset AF doubles with each successive decade after 50 years with 10% of patients in their eighth decade suffering from this condition [7]. Independent risk factors for the development of AF include increasing age, diabetes, left ventricular hypertrophy, coronary heart disease, and valvular heart disease [8]. The Coronary Artery Surgery Study registry revealed that 116 (0.6%) of 18,343 patients with angiographically demonstrated coronary artery disease had AF [9], while 38-year follow-up data from The Framingham Study have shown that valvular heart disease is associated with a 1.8-fold increase of AF in men and a 3.4-fold increase in women [7, 8]. The prevalence of AF in patients with mitral valve disease ranges between 30% and 84% [10, 11].
 |
Mechanisms of AF
|
|---|
Understanding the mechanisms of AF lies at the fulcrum of its treatment, especially with the recent introduction of reduced ablation lines applied percutaneously and surgically. It is important to distinguish the "triggers" from "drivers." Haissaguerre and colleagues [12] reported that paroxysmal AF is induced by triggers located in the pulmonary veins in approximately 90% of cases and lie outside the region of the pulmonary veins in the remaining 10%. Therefore, 90% of patients with paroxysmal AF should be cured with pulmonary vein isolation alone.
An issue of controversy is what comprises the drivers causing continuous AF. Is it the macro reentry circuits in the atria or the triggers in the pulmonary veins? The Cox-maze procedure has been based on the concept of the macro reentry circuits based in the atria that perpetuate AF [13]. This concept has been supported by the computer models devised by Moe and colleagues [14], where multiple wandering wavelets are present during AF. It is further supported by Allessie [15] demonstrating that AF induces both electrophysiologic and structural changes in the atria favoring its maintenance. Therefore, to abolish AF the macro reentrant circuits have to be interrupted and simple pulmonary vein isolation will have little role in the treatment of chronic AF [16].
Others believe that drivers to AF are predominantly within pulmonary veins and therefore pulmonary vein isolation for chronic AF should suffice [17]. To support this theory, Todd and colleagues [18] have reported 14 patients with chronic AF with excellent clinical outcome. However, in their study they did not solely perform pulmonary vein isolation, but also performed left atrial excision, pulmonary vein to mitral annulus line, and cryoablation of the right atrial isthmus. Sahadevan and colleagues [19] showed that a driver in the pulmonary vein may be responsible for chronic AF. Others have reported that a more circumferential isolation of the pulmonary veins, including the antrum of the pulmonary veins, increases the ablation success [20, 21]. Therefore, it may be that the drivers are not placed solely in the pulmonary veins, and by extending the ablation area into the antrum of the pulmonary veins and the left atrium, the macro reentrant circuits are interrupted.
 |
Surgical Procedures
|
|---|
Cox-Maze
The Cox-maze procedure (CMP) was first introduced in 1991 [13] in a small series of seven patients. Follow-up studies of the first 32 patients who underwent CMP I at six months showed an increased incidence of a blunted sinus node response to maximum exercise and a high incidence of left atrial dysfunction and increased pacemaker implantation [22]. The CMP II had similar problems and required transection of the superior vena cava, and therefore it was thought technically demanding and was subsequently abandoned [23]. Therefore, surgical technique was modified and CMP III evolved [24]. This has been considered the optimum surgical technique for treatment of refractory atrial flutter and AF. Cox and colleagues, in their subsequent series [25], have reported freedom from AF at 10 years with CMP III of 89.3%, but 75.4% and 83.6% with CMP I and II, respectively [25]. The operative mortality in their series has been 1.2% to 1.8% [26] with reoperation for bleeding of up to 7%.
Similar results have been reported by the Cleveland group [27] with a 30-day mortality of 1%, restoration of sinus rhythm in 90% at a mean follow-up of three years, and perioperative pacemaker implantation of 6%. However, not all groups have matched these results. Izumoto and colleagues [28], in a series of 87 patients, have reported a mortality of 4.6%, restoration of sinus rhythm of 79.5%, and reoperation for bleeding of 8% (Table 1). Due to the technical demands and variable outcomes the CMP III has evolved with many surgical modifications, with or without energy-based techniques to simplify the original operation.
Several groups have chosen to omit some of the incisions of CMP III. This has made comparison of results difficult. The discrepancy in the results of different series and, in some reports, inferior results to CMP III may be due to the omission of some of these surgical lines or the inadequacy of energy-based techniques.
Mini-Partial Maze
These are procedures where one or more lines of ablation of the CMP III have been modified, omitted, or replaced with an energy-based technique [29, 30]. Schaff and colleagues [31], in their series of 221 patients, omitted the incision along the medial aspect of the right atrium from the tricuspid annulus to the cut edge of the right atrial appendage and instead applied lines of cryolesion to the atrial myocardium to minimize the risk of interruption of the coronary blood supply to the sinoatrial node. They have reported a mortality of 1.4%, bleeding of 5%, and a pacemaker implantation of 3.2%. In the majority of the partial maze procedures, the coronary sinus lesions are omitted, which can increase the risk of atrial flutter [32]. There are several reports of the partial maze procedures using various forms of energy.
 |
Energy-Based Procedures
|
|---|
In an attempt to simplify CMP III, reduce cardiopulmonary bypass, cross-clamp times, and perioperative bleeding associated with CMP III and its modifications, use of energy source has replaced some or all of the incisions of the original operation. Generally, energy-based techniques are less effective than pure CMP III.
Transmural lesions are believed to be necessary to prevent escape of energy resulting in breakthrough of AF. The lesions produced have to be in continuity directly or have additional surgical lines to avoid breakthrough of AF. The ideal source of energy and device should achieve transmurality, cause no damage to the neighboring structures, provide fast application, and have malleable, nonbulky probes.
Radiofrequency
This type of energy uses alternating electrical current of 100 KHz to 1 MHz to heat tissue, reaching temperatures of 80°C in one minute [33]. There are several studies reporting on the use of radiofrequency (RF) energy in the treatment of AF. As stated earlier, it is difficult to compare and contrast these studies due to variable classification of AF, methodology, and follow-up. Furthermore, pacemaker implantation rate is reported at different follow-up intervals. The results of some of these studies are shown in Table 2. The average freedom from AF varies between 70% and 90%. The majority have used unipolar RF ablation. Sie and colleagues [34] have used unipolar irrigated, Gillinov and McCarthy [35] and Mokadam and colleagues [36] have used bipolar, and Khargi and colleagues [37] have used unipolar irrigated systems.
Unipolar Versus Bipolar Radiofrequency
The unipolar probe drives the current from an active electrode to an indifferent electrode and back to the generator. The current is converted into thermal energy and the high temperatures produced at tissue level can cause vaporization and charring. With the unipolar probe, energy travels both through the tissue and in a multidirectional manner. The latter can result in damage of the neighboring structures [38] like the esophagus and coronary arteries [39, 40]. A further disadvantage of the unipolar probe is the uncertainty of transmurality, especially when used on the beating heart [41]. Sie and colleagues [42] used the unipolar probe and performed a complete CMP III, achieving 78% freedom from AF. These are comparable with other surgical series [43, 44].
The bipolar system provides both epicardial and endocardial therapy. Prasad and colleagues [45] have demonstrated several advantages of bipolar in animal experimentation. With bipolar, the tissue receives just enough energy to produce a transmural lesion and shortening ablation time. It also decreases thermal spread and thus reduces the amount of nearby tissue subject to contracture and subsequent stenosis. Contracture and pulmonary vein stenosis are seen with percutaneous catheter ablation [46]. In addition, a bipolar system would avoid damage to the mediastinal structures at the back of the heart.
Irrigated Versus Nonirrigated Radiofrequency
Irrigated systems using saline-irrigated cooled tip catheters or bipolar probes allow delivery of a higher amount of energy due to improved conductivity created by the use of saline. The normal saline irrigation cools the surface tissue and lowers the impedance at the tissue-electrode interface, improving efficacy [47, 48].
Microwave
The mechanism of ablation using microwave is by heating. Microwaves cause oscillation of water molecules in tissue, converting electromagnetic energy into heat. The microwave energy penetrates the tissues at different depths depending on the type of probe. There are several articles on microwave ablation for surgical treatment of AF [4951], reporting success rates of 70% to 90%. The epicardial approach is less commonly applied.
Cryothermy
Cryothermy ablates tissue as intracellular ice crystals disrupt cell membranes while leaving collagen structure intact. Lesions created by cryothermy heal by fibrosis, leaving a dense homogenous lesion. It has long been in use by both cardiologists and surgeons [13, 22]. Cox and Ad have [32] reported its use in ablation of the coronary sinus. Nakajima and colleagues [52] have shown that the use of cryothermy can decrease cardiopulmonary bypass and cross-clamp time with significantly less chest tube drainage. It can be applied both endocardially and epicardially and produces no char. The original cryoprobes were rigid, making their use difficult. However, the new probes have a flexible 6-cm cooling segment that can be shaped to different anatomic structures.
Gillinov and colleagues [53] have compared and contrasted these various forms of energy and have concluded that assessment of transmurality is really only available for radiofrequency and not for microwave and cryothermy. However, the latter two forms of energy do not produce any charring compared with radiofrequency. Several other issues and alternatives of the CMP III pattern, which are thought to influence the outcome of surgery, are discussed below.
 |
Effect of Concomitant Surgery
|
|---|
Cox and colleagues [54] report their results of CMP III in 83 patients who underwent 96 valve procedures with an overall mortality of 6% compared with 1.9% in those not having valve surgery. The incidence of perioperative atrial arrhythmias was the same in both groups. Multivariate analysis of the cohort showed that concomitant valve surgery was not an independent risk factor. Others have reported a lower freedom from AF with concomitant procedures, but this may be due to different surgical techniques and incomplete CMP III [28]. The cardiopulmonary bypass and cross-clamp times have been longer in concomitant procedures, but these results are from earlier studies and generally these times have been reduced in more recent studies especially with the use of energy-based techniques [41]. The type of lesions required for the treatment of AF should be determined according to the type of AF and not according to the need for concomitant procedure.
 |
Is Pulmonary Vein Isolation Sufficient?
|
|---|
Is pulmonary vein isolation (PVI) sufficient for treatment of all forms of AF and does it provide as good a freedom from AF compared with CMP III? The answer to this question lies with whether the drivers of AF causing chronicity are within the pulmonary vein [17] or are the macro reentrant circuits within the atria [15]. If the former theory holds, the PVI should be sufficient for treatment of all forms of AF. In a recent (between 2000 and 2002) worldwide survey of catheter ablation for AF where disconnection of multiple pulmonary veins was performed, success rates of freedom from antiarrhythmic drugs were the following: 52.7% in 65 centers including patients with paroxysmal AF; 48.5% in 17 centers including patients with paroxysmal or persistent AF; and 57.3% in 8 centers including patients with all forms of AF [55]. In this report significant pulmonary vein stenosis and strictures occurred in 1.3% and 0.2% of patients, respectively. The overall incidence of major complications was 6%. Half of the patients with pulmonary vein stenosis required interventional treatment, a method that does not necessarily abolish symptoms [56]. Therefore, it seems that PVI may be inadequate for persistent-permanent AF. However, if the driver theory holds, pure PVI for paroxysmal AF should suffice for the majority of the patients. For the minority of patients with paroxysmal AF, patients who may have different foci outside the pulmonary veins, additional lesions will be required.
 |
Patients With Large Atria
|
|---|
Lammers and colleagues [57] have demonstrated that the left atrial refractory period is shorter than the right atrial. Therefore, the maintenance of AF in the right atrium will probably be possible only if it is enlarged. In patients with normal size atria, the treatment of AF can be directed to the left atrium avoiding recurrence due to its shorter refractory periods. However, in patients with large right atriums, additional right atrial ablation lines will be required.
 |
Importance of the Coronary Sinus Lesion
|
|---|
In most studies it is difficult to elicit whether coronary sinus ablation has been performed. Cox and Ad [32] have emphasized the importance of coronary sinus ablation. Furthermore, Nakagawa and colleagues [58] have emphasized the importance of the isthmus line between the coronary sinus and the tricuspid valve, responsible for the majority of atrial flutters. Chauvin and colleagues [59] carried out a study of ten necropsied hearts, where they showed striated muscle around the coronary sinus connecting inferior right atrium to left atrium. This anatomy was shown to have variable morphology, which may account for inconsistent results reported for left atrial isolation.
 |
Endocardial Versus Epicardial Ablation
|
|---|
In recent years, minimally invasive techniques have been developed that use epicardial beating heart ablation [6062]. The effectiveness of epicardial beating heart surgery is affected by the epicardial fat and cooling effect of circulating blood, compared with endocardial ablation on the arrested heart. In a study using RF energy in ovine myocardium with different wall thickness, Thomas and colleagues [63] showed that epicardial fat has a negative effect on lesion formation. Even when fat was absent, epicardial RF energy resulted in smaller lesions compared with endocardial application. Similarly, Santiago and colleagues [64], in their in vitro experiments of human atrial walls and analysis of left atrial lesions in patients undergoing mitral valve surgery using epicardial RF ablation, showed that the thickness and composition of the epicardium and the myocardium play an important role in the formation of the myocardial lesion. Furthermore, Accord and colleagues [65], performing histologic analysis of epicardial lesions of three postmortem cases, showed that transmurality was not achieved in the majority of the samples and the extent of myocardial damage was variable. These findings may have implications in patients undergoing redo surgery and those with mitral valve disease and thickened atria.
 |
Innervation of the Pulmonary Veins and Atria: Effect on AF Ablation
|
|---|
Abnormal conduction of the autonomic nervous system can trigger or perpetuate AF [66]. Both the adrenergic and cholinergic systems may be involved in initiation and maintenance of AF. There is accumulating evidence that the activation of autonomic ganglia, specifically of the ganglion plexus at the base of the right superior pulmonary vein, may serve as a mediating factor for initiation of AF by pulmonary vein depolarization [67]. About one third of patients undergoing left atrial circumferential ablation demonstrated ganglion plexus involvement. Application of RF at these sites may increase the success rate of ablation. Furthermore, there are reports of autonomic dysfunction after AF ablation [68, 69]. Chevalier and colleagues [70] carried out a quantitative study of the innervation of the left atrium and pulmonary veins. They showed that the most densely innervated sites are the left and posterior parts of the atrium and the antrum of the pulmonary veins. These innervation gradients may contribute to the electrical propagation during AF. There are reports of neural ablation using RF for the treatment of AF [71, 72]. In addition, Pappone and colleagues [67] and Lonnerholm and colleagues [68] have demonstrated that denervation improves AF ablation. Therefore, targeting the most innervated areas should increase the success of ablation using surgical and percutaneous techniques.
 |
Catheter Ablation of AF
|
|---|
Following the landmark observation by Haissaguerre and colleagues [12], demonstrating that impulses originating in the pulmonary veins could initiate AF, several groups developed percutaneous catheter ablation of AF [55]. In general, three different approaches for the treatment of AF have been suggested: (1) focal ablation within the pulmonary veins guided by the endocardial activation time [73]; (2) anatomically based pulmonary vein isolation by circumferential ablation at their ostia [74]; and (3) segmental isolation of pulmonary veins guided by the detection of high-frequency depolarizations within the ostia (pulmonary vein potentials) [75]. Separate encirclement of left-sided and right-sided pulmonary veins (antral ablation) is a modification of circumferential ablation. Focal ablation within veins guided by activation mapping has been abandoned because of unreliable provocation of focal firing, modest success rates, and risk of pulmonary vein stenosis.
The results of several catheter ablation studies are summarized in Table 3. Similar to surgical reports, it is difficult to compare and contrast these studies due to different classification, patient cohorts, technique used, and follow-up period. Freedom from atrial fibrillation achieved is significantly better for paroxysmal AF (5985%) compared with permanent-persistent AF (525%). The complications associated with catheter ablation include pericardial effusion and tamponade secondary to perforation (
5%), stroke and transient ischemic attacks (
4%), pulmonary vein stenosis (342%), and sinus node dysfunction.
Some of the limitations of the percutaneous ablation include achieving transmurality and continuity of the ablation lines, and prolonged procedural time, sometimes up to five hours [76]. Multiple gaps in the ablation line may result not only in recurrent AF, but also promoting new arrhythmias such as left atrial macro reentry, often requiring additional intervention. In canine experiments, gaps as narrow as 2 mm demonstrated normal conduction during atrial pacing. Employing three-dimensional anatomic mapping and double Lasso catheters in combination with adenosine provocation may improve identification of gaps in left atrial lines [71].
In summary, the type of lesion required for treatment of AF should be determined according to the type of AF, irrespective of the need for concomitant procedures. For patients with paroxysmal AF, PVI should suffice in approximately 90% of patients and the remainder will need additional lines of ablation performed. Both catheter ablation and surgical results indicate that in patients with permanent-persistent AF, PVI is insufficient and additional surgical lines are required, like right atrial ablation lines in patients with large right atria.
The future directions should determine the balance and efficacy of epicardial and endocardial approaches in the treatment of both permanent- persistent AF. Further studies, such as identification of triggers outside the pulmonary veins and the role of autonomic innervation, are required to improve the understanding of mechanisms of AF. Advances in these fields would enable surgeons and cardiologists to further the management of AF with improved results, and using minimal access techniques [77, 78] including robotic surgery with or without the use of cardiopulmonary bypass.86
 |
References
|
|---|
- Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillationexecutive summary a report of the American College of Cardiology/American Heart Association Task Force. Circulation 2001;104:2118-2150.[Free Full Text]
- Sopher M, Camm J. Atrial fibrillationmaintenance of sinus rhythm versus rate control. Am J Cardiol 1996;77:24A-37A.[Medline]
- Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation Circulation 2001;103:769-777.[Free Full Text]
- Chugh SS, Blackshear JL, Shen W-K, et al. Epidemiology and natural history of atrial fibrillationclinical implications. J Am Coll Cardiol 2001;37:371-378.[Abstract/Free Full Text]
- Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summarya report of the American College of Cardiology/American Heart Association Task Force. Circulation 2003;108:1871-1909.[Free Full Text]
- Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillationAnalysis and implications. Arch Intern Med 1995;155:469-473.[Abstract/Free Full Text]
- Kannel W, Wolf P, Benjamin E, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillationpopulation-based estimates. Am J Cardiol 1998;82:2n-9n.
- Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of deathThe Framingham Heart Study. Circulation 1998;98:946-952.[Abstract/Free Full Text]
- Cameron A, Schwartz M, Kronmal R, Kosinski A. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS registry) Am J Cardiol 1988;61:714-717.[Medline]
- Brodell G, Cosgrove D, Schiavone W, et al. Cardiac rhythm and conduction disturbances in patients undergoing mitral valve surgery Cleve Clin J Med 1991;58:397-399.[Medline]
- Chua L, Schaff H, Orszulak T, Morris J. Outcome of mitral valve repair in patients with preoperative atrial fibrillation J Thorac Cardiovasc Surg 1994;107:408-415.[Abstract/Free Full Text]
- Haissaguerre M, Jais M, Shah D. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 1998;3396596.
- Cox J, Schuessler R, D'Agostino H. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure J Thorac Cardiovasc Surg 1991;101:569-583.[Abstract]
- Moe G, Rheinboldt W, Abildskov J. A computer model of atrial fibrillation Am Heart J 1964;67:201-220.
- Allessie M. Atrial fibrillation-induced electrical remodeling in humanswhat is the next step?. Cardiovasc Res 1999;44:10-12.[Free Full Text]
- Cox JL. The central controversy surrounding the interventional-surgical treatment of atrial fibrillation J Thorac Cardiovasc Surg 2005;129:1-4.[Free Full Text]
- Morady F. Catheter ablation of supraventricular arrhythmias Pacing Clin Electrophysiol 2004;27:125-142.[Medline]
- Todd DM, Skanes AC, Guiraudon G, et al. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillationelectrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation 2003;108:3108-3114.[Abstract/Free Full Text]
- Sahadevan J, Ryu K, Peltz L. Epicardial mapping of chronic atrial fibrillation in patients. Preliminary observations Circulation 2004;110:3293-3299.[Abstract/Free Full Text]
- Nakagawa H, Aoyama H, Beckman K, et al. Relation between pulmonary vein firing and extent of left atrial-pulmonary vein connection in patients with atrial fibrillation Circulation 2004;109:1523-1529.[Abstract/Free Full Text]
- Pappone C, Oreto G, Rosanio S. Atrial electroanatomical remodeling after circumferential radiofrequency pulmonary vein ablationefficacy of anatomical approach in a large cohort of patients with atrial fibrillation. Circulation 2001;104:2539-2544.[Abstract/Free Full Text]
- Cox J, Boineau J, Schuessler R. Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rational and surgical results J Thorac Cardiovasc Surg 1995;110:473-483.[Abstract/Free Full Text]
- Cox J. Evolving applications of the maze procedure for atrial fibrillation Ann Thorac Surg 1993;55:578-580.[Medline]
- Cox JL, Boineau JP, Schuessler RB, et al. Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure J Thorac Cardiovasc Surg 1995;110:485-495.[Abstract/Free Full Text]
- Prasad S, Maniar H, Camillo C, et al. The Cox maze III procedure for atrial fibrillationlong-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg 2003;126:1822-1827.[Abstract/Free Full Text]
- Cox J, Ad N, Palazzo T, et al. Current status of the Maze procedure for the treatment of atrial fibrillation Semin Thorac Cardiovasc Surg 2000;12:15-19.[Medline]
- McCarthy P, Gillinov A, Castle L, et al. The Cox-Maze procedurethe Cleveland Clinic experience. Semin Thorac Cardiovasc Surg 2000;12:25-29.[Medline]
- Izumoto H, Kawazoe K, Kitahara H, Kamata J. Operative results after the Cox/maze procedure combined with a mitral valve operation Ann Thorac Surg 1998;66:800-804.[Abstract/Free Full Text]
- Takami Y, Tyasuura K, Takagi Y, et al. Partial maze procedure is effective treatment for chronic atrial fibrillation associated with valve disease J Card Surg 1999;14:103-108.[Medline]
- Szalay Z, Skwara W, Pitchner H, et al. Midterm results after the mini-maze procedure Eur J Cardiothorac Surg 1999;16:306-311.[Abstract/Free Full Text]
- Schaff H, Dearani J, Daly R, et al. Cox-Maze procedure for atrial fibrillationMayo Clinic experience. Semin Thorac Cardiovasc Surg 2000;12:30-37.[Medline]
- Cox J, Ad N. The importance of cryoablation of the coronary sinus during the maze procedure Semin Thorac Cardiovasc Surg 2000;12:20-24.[Medline]
- Williams MR, Stewart JR, Bolling SF, et al. Surgical treatment of atrial fibrillation using radiofrequency energy Ann Thorac Surg 2001;71:1939-1944.[Abstract/Free Full Text]
- Sie HT, Beukema WP, Elvan A, Ramdat Misier AR. Long-term results of irrigated radiofrequency modified maze procedure in 200 patients with concomitant cardiac surgerysix years experience. Ann Thorac Surg 2004;77:512-517.[Abstract/Free Full Text]
- Gillinov AM, McCarthy PM. Atricure bipolar radiofrequency clamp for intraoperative ablation of atrial fibrillation Ann Thorac Surg 2002;74:2165-2168.[Abstract/Free Full Text]
- Mokadam NA, McCarthy PM, Gillinov AM, et al. A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillationearly results. Ann Thorac Surg 2004;78:1665-1670.[Abstract/Free Full Text]
- Khargi K, Deneke T, Lemke B, Laczkovics A. Irrigated radiofrequency ablation is a safe and effective technique to treat chronic atrial fibrillation Interactive Cardiovascular and Thoracic Surgery 2003;2:241-245.[Abstract/Free Full Text]
- Langberg J, Lee M, Chin M, Rosenqvist M. Radiofrequency catheter ablationthe effect of electrode size on lesion volume in vivo. Pacing Clin Electrophysiol 1990;13:1242-1248.[Medline]
- Gillinov AM, McCarthy PM, Pettersson G, Lytle BW, Rice TW. Esophageal injury during radiofrequency ablation for atrial fibrillation J Thorac Cardiovasc Surg 2001;122:1230-1240.
- Mohr FW, Fabricius AM, Falk V, et al. Curative treatment of atrial fibrillation with intraoperative radiofrequency ablationshort-term and midterm results. J Thorac Cardiovasc Surg 2002;123:919-927.[Abstract/Free Full Text]
- Hoenicke E, Strange R, Patel H. Epicardial radiofrequency ablation on the beating heartmoving towards a less invasive MAZE procedure. Surg Forum 2000;51:79-82.
- Sie HT, Beukema WP, Misier ARR, et al. Radiofrequency modified maze in patients with atrial fibrillation undergoing concomitant cardiac surgery J Thorac Cardiovasc Surg 2001;122:249-256.[Abstract/Free Full Text]
- Kosakai Y, Kawaguchi A, Isobe F, et al. Cox maze procedure for chronic atrial fibrillation associated with mitral valve disease J Cardiovasc Electrophysiol 1994;108:1049-1055.
- Kamata J, Kawazoe K, Izumoto H, et al. Predictors of sinus rhythm restoration after Cox Maze procedure concomitant with other cardiac operations Ann Thorac Surg 1997;64:394-398.[Abstract/Free Full Text]
- Prasad SM, Maniar HS, Diodato MD, et al. Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veinsa chronic animal study. Ann Thorac Surg 2003;76:836-842.[Abstract/Free Full Text]
- Yu W, Hsu T, Tai C, et al. Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation J Cardiovasc Electrophysiol 2001;12:887-892.[Medline]
- Shimoike E, Kaji Y, Ueda N, et al. In vivo and in vitro study of radio-frequency application with a new long linear probe J Thorac Cardiovasc Surg 2000;120:164-172.[Abstract/Free Full Text]
- Scavee C, Jais P, Hsu L-F, et al. Prospective randomised comparison of irrigated-tip and large-tip catheter ablation of cavotricuspid isthmus-dependent atrial flutter Eur Heart J 2004;25:963-969.[Abstract/Free Full Text]
- Williams M, Argenziano M, Oz M. Microwave ablation for surgical treatment of atrial fibrillation Semin Thorac Cardiovasc Surg 2002;14:232-237.[Medline]
- Williams M, Knaut M, Berube D. Application of microwave energy in cardiac tissue ablationfrom in vitro analysis to clinical use. Ann Thorac Surg 2002;74:1500-1505.[Abstract/Free Full Text]
- Knaut M, Tugtekin S, Spitzer S. Combined atrial fibrillation and mitral valve surgery using microwave technology Semin Thorac Cardiovasc Surg 2002;14:226-231.[Medline]
- Nakajima H, Kobayashi J, Bando K, et al. The effect of cryo-maze procedure on early and intermediate term outcome in mitral valve diseasecase matched study. Circulation 2002;106:I46-I50.
- Gillinov AM, Blackstone EH, McCarthy PM. Atrial fibrillationcurrent surgical options and their assessment. Ann Thorac Surg 2002;74:2210-2217.[Abstract/Free Full Text]
- Cox JL, Ad N, Palazzo T, et al. The Maze-III procedure combined with valve surgery Seminars Cardiovasc Surg 2000;12:53-55.
- Cappato R, Calkins H, Chen S, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circulation 2005;111:1100-1105.[Abstract/Free Full Text]
- Saad E, Marrouche N, Saad C, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillationemergence of a new clinical syndrome. Ann Intern Med 2003;138:634-638.[Abstract/Free Full Text]
- Lammers W, Schalij M, Kirchhof C, Allessie MA. Quantification of spatial inhomogenity in conduction and initiation of reentrant atrial arrhythmias Am J Physiol 1990;258:H1254-H1263.
- Nakagawa H, Lazzara R, Khastgir T, et al. Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutterrelevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation 1996;94:407-424.[Abstract/Free Full Text]
- Chauvin M, Shah D, Haissaguerre M, et al. The anatomic basis of connections between the coronary sinus musculature and the left atrium in humans Circulation 2000;101:647-652.[Abstract/Free Full Text]
- Maesson JG, Nijs JFMA, Smeets JLRM, et al. Beating heart surgical treatment of atrial fibrillation with microwave ablation Ann Thorac Surg 2002;74:S1307-S1311.[Abstract/Free Full Text]
- Prasad SM, Maniar HS, Schuessler RB, Damaino Jr RJ. Chronic transmural atrial ablation by using bipolar radiofrequency energy on the beating heart J Thorac Cardiovasc Surg 2002;124:708-713.[Abstract/Free Full Text]
- Argenazio M, Williams MR. Robotic atrial septal defect repair and endoscopic treatment of atrial fibrillation Semin Thorac Cardiovasc Surg 2003;15:130-140.[Medline]
- Thomas SP, Guy DJR, Boyd AC, Eipper VE, Ross DL, Chard RB. Comparison of epicardial and endocardial linear ablation using handheld probes Ann Thorac Surg 2003;75:543-548.[Abstract/Free Full Text]
- Santiago T, Melo J, Gouveia RH, et al. Epicardial radiofrequency applicationsin vitro and in vivo studies on human atrial myocardium. Eur J Cardiothorac Surg 2003;24:481-486.[Abstract/Free Full Text]
- Accord RE, van Suylen RJ, van Brakel TJ, Maessen JG. Post-mortem histologic evaluation of microwave lesions after epicardial pulmonary vein isolation for atrial fibrillation Ann Thorac Surg 2005;80:881-887.[Abstract/Free Full Text]
- De Ferrari G, Schwartz P. Autonomic nervous system and arrhythmias Ann N Y Acad Sci 1990;601:247-262.[Medline]
- Pappone C, Santinelli V, Manguso F, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation Circulation 2004;109:327-334.[Abstract/Free Full Text]
- Lonnerholm S, Blomstrom P, Nilsson L, et al. Autonomic denervation after the Maze procedure Pacing Clin Electrophysiol 2003;26:587-592.[Medline]
- Hseih MH, Chiou CW, Wen ZC, et al. Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins Circulation 1999;100:2237-2243.[Abstract/Free Full Text]
- Chevalier P, Tabib A, Meyronnet D, et al. Quantitative study of nerves of the human left atrium Heart Rhythm 2005;5:518-522.
- Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes. The third fat pad Circulation 1997;95:2573-2584.[Abstract/Free Full Text]
- Schauerte P, Scherlag BJ, Pitha J, et al. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation Circulation 2000;102:2774-2780.[Abstract/Free Full Text]
- Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veinselectrophysiologic characteristics, pharmacologic responses, and effects of radiofrequency catheter ablation. Circulation 1999;100:1879-1886.[Abstract/Free Full Text]
- Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia Circulation 2000;102:2619-2628.[Abstract/Free Full Text]
- Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillationsegmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003;108:2355-2360.[Abstract/Free Full Text]
- Pappone C, Oreto G, Lamberti F, et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system Circulation 1999;100:1203-1208.[Abstract/Free Full Text]
- Cox JL. The minimally invasive Maze-III procedure Oper Tech Thorac Cardiovasc Surg 2000;5:79-92.
- van Brakel TJ, Bolotin G, Nifong LW, et al. Robot-assisted epicardial ablation of the pulmonary veinsis a completed isolation necessary?. Eur Heart J 2005;26:1321-1326.[Abstract/Free Full Text]
- Benussi S, Nascimbene S, Agricola E, et al. Surgical ablation of atrial fibrillation using the epicardial radiofrequency approachmid-term results and risk analysis. Ann Thorac Surg 2002;74:1050-1056.[Abstract/Free Full Text]
- Sie HT, Beukema WP, Ramdat Misier AR, Elvan A, Ennema JJ, Wellens HJJ. The radiofrequency modified maze procedure. A less invasive surgical approach to atrial fibrillation during open-heart surgery Eur J Cardiothorac Surg 2001;19:443-447.[Abstract/Free Full Text]
- Melo J, Adragao P, Neves J, et al. Surgery for atrial fibrillation using radiofrequency catheter ablationassessment of results at one year. Eur J Cardiothorac Surg 1999;15:851-855.[Abstract/Free Full Text]
- Wellens F, Casselman F, Geelen P, et al. Combined atrial fibrillation and mitral valve surgery using radiofrequency technology Semin Thorac Cardiovasc Surg 2002;14:219-225.[Medline]
- Gaynor SL, Diodato MD, Prasad SM, et al. A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation J Thorac Cardiovasc Surg 2004;128:535-542.[Abstract/Free Full Text]
- Guden M, Akpinar B, Sanisoglu I, et al. Intraoperative saline-irrigated radiofrequency modified maze procedure for atrial fibrillation Ann Thorac Surg 2002;74:S1301-S1306.[Abstract/Free Full Text]
- Geidel S, Laas M, Boczor S, et al. Surgical treatment of permanent atrial fibrillation during heart valve surgery Interactive CardioVascular and Thoracic Surgery 2003;2:160-165.[Abstract/Free Full Text]
- Golovchiner G, Mazur A, Kogan A, et al. Atrial flutter after surgical radiofrequency ablation of the left atrium for atrial fibrillation Ann Thorac Surg 2005;79:108-112.[Abstract/Free Full Text]
- Raman J, Ishikawa S, Storer MM, Power JM. Surgical radiofrequency ablation of both atria for atrial fibrillationresults of a multicenter trial. J Thorac Cardiovasc Surg 2003;126:1357-1365.[Abstract/Free Full Text]
- Haissaguerre M, Jais P, Shah D, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci Circulation 2000;101:1409-1417.[Abstract/Free Full Text]
- Oral H, Knight B, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation Circulation 2002;105:1077-1081.[Abstract/Free Full Text]
- Ernst S, Ouyang F, Lober F, Antz M, Kuck KH. Catheter-induced linear lesions in the left atrium in patients with atrial fibrillationan electroanatomic study. J Am Coll Cardiol 2003;42:1271-1282.[Abstract/Free Full Text]
- Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillationmapping of the electrophysiologic substrate. Am Coll Cardiol 2004;43:2044-2053.[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
I. Savelieva and J. Camm
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
Europace,
June 1, 2008;
10(6):
647 - 665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kourliouros, A. De Souza, N. Roberts, A. Marciniak, A. Tsiouris, O. Valencia, J. Camm, and M. Jahangiri
Dose-Related Effect of Statins on Atrial Fibrillation After Cardiac Surgery
Ann. Thorac. Surg.,
May 1, 2008;
85(5):
1515 - 1520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Onorati, A. Esposito, G. Messina, A. di Virgilio, and A. Renzulli
Right Isthmus Ablation Reduces Supraventricular Arrhythmias After Surgery for Chronic Atrial Fibrillation
Ann. Thorac. Surg.,
January 1, 2008;
85(1):
39 - 48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sagbas, B. Akpinar, I. Sanisoglu, B. Caynak, B. Tamtekin, K. Oral, and B. Onan
Video-Assisted Bilateral Epicardial Pulmonary Vein Isolation for the Treatment of Lone Atrial Fibrillation
Ann. Thorac. Surg.,
May 1, 2007;
83(5):
1724 - 1730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Bakir, F. P. Casselman, P. Brugada, P. Geelen, F. Wellens, I. Degrieck, F. Van Praet, Y. Vermeulen, R. De Geest, and H. Vanermen
Current Strategies in the Surgical Treatment of Atrial Fibrillation: Review of the Literature and Onze Lieve Vrouw Clinic's Strategy
Ann. Thorac. Surg.,
January 1, 2007;
83(1):
331 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|